Global Model Organism Market Research Report 2024

Publication ID:

PB504245006

Publication Date:

April 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

A model organism is a species that has been widely studied, usually because it is easy to maintain and breed in a laboratory setting and has particular experimental advantages. Model organisms are non-human species that are used in the laboratory to help scientists understand biological processes.
The global Model Organism market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Model Organism is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Model Organism is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Model Organism in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Model Organism include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Model Organism, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Model Organism.
Report Scope
The Model Organism market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Model Organism market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Model Organism companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Prokaryote
Eukaryote
Segment by Application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Model Organism companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Model Organism Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prokaryote
1.2.3 Eukaryote
1.3 Market by Application
1.3.1 Global Model Organism Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Model Organism Market Perspective (2019-2030)
2.2 Model Organism Growth Trends by Region
2.2.1 Global Model Organism Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Model Organism Historic Market Size by Region (2019-2024)
2.2.3 Model Organism Forecasted Market Size by Region (2025-2030)
2.3 Model Organism Market Dynamics
2.3.1 Model Organism Industry Trends
2.3.2 Model Organism Market Drivers
2.3.3 Model Organism Market Challenges
2.3.4 Model Organism Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Model Organism Players by Revenue
3.1.1 Global Top Model Organism Players by Revenue (2019-2024)
3.1.2 Global Model Organism Revenue Market Share by Players (2019-2024)
3.2 Global Model Organism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Model Organism Revenue
3.4 Global Model Organism Market Concentration Ratio
3.4.1 Global Model Organism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Model Organism Revenue in 2023
3.5 Model Organism Key Players Head office and Area Served
3.6 Key Players Model Organism Product Solution and Service
3.7 Date of Enter into Model Organism Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Model Organism Breakdown Data by Type
4.1 Global Model Organism Historic Market Size by Type (2019-2024)
4.2 Global Model Organism Forecasted Market Size by Type (2025-2030)
5 Model Organism Breakdown Data by Application
5.1 Global Model Organism Historic Market Size by Application (2019-2024)
5.2 Global Model Organism Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Model Organism Market Size (2019-2030)
6.2 North America Model Organism Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Model Organism Market Size by Country (2019-2024)
6.4 North America Model Organism Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Model Organism Market Size (2019-2030)
7.2 Europe Model Organism Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Model Organism Market Size by Country (2019-2024)
7.4 Europe Model Organism Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Model Organism Market Size (2019-2030)
8.2 Asia-Pacific Model Organism Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Model Organism Market Size by Region (2019-2024)
8.4 Asia-Pacific Model Organism Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Model Organism Market Size (2019-2030)
9.2 Latin America Model Organism Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Model Organism Market Size by Country (2019-2024)
9.4 Latin America Model Organism Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Model Organism Market Size (2019-2030)
10.2 Middle East & Africa Model Organism Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Model Organism Market Size by Country (2019-2024)
10.4 Middle East & Africa Model Organism Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Detail
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Model Organism Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Model Organism Business (2019-2024)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Detail
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Model Organism Introduction
11.2.4 Gem Pharmatech Co., Ltd. Revenue in Model Organism Business (2019-2024)
11.2.5 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Model Organism Introduction
11.3.4 Charles River Laboratories Revenue in Model Organism Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo Model Organism Introduction
11.4.4 Envigo Revenue in Model Organism Business (2019-2024)
11.4.5 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Model Organism Introduction
11.5.4 Taconic Biosciences Revenue in Model Organism Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Detail
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Model Organism Introduction
11.6.4 Jackson Laboratory Revenue in Model Organism Business (2019-2024)
11.6.5 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Detail
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Model Organism Introduction
11.7.4 Shanghai SLAC Revenue in Model Organism Business (2019-2024)
11.7.5 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Detail
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Model Organism Introduction
11.8.4 Joinn Laboratories Revenue in Model Organism Business (2019-2024)
11.8.5 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Detail
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Model Organism Introduction
11.9.4 Crown Biosciences Revenue in Model Organism Business (2019-2024)
11.9.5 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Detail
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Model Organism Introduction
11.10.4 Pharmalegacy Revenue in Model Organism Business (2019-2024)
11.10.5 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Detail
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Model Organism Introduction
11.11.4 Syngene International Revenue in Model Organism Business (2019-2024)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Detail
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Model Organism Introduction
11.12.4 Janvier Labs Revenue in Model Organism Business (2019-2024)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Detail
11.13.2 GenOway Business Overview
11.13.3 GenOway Model Organism Introduction
11.13.4 GenOway Revenue in Model Organism Business (2019-2024)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Detail
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Model Organism Introduction
11.14.4 Psychogenics Revenue in Model Organism Business (2019-2024)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Detail
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Model Organism Introduction
11.15.4 Horizon Discovery Group Revenue in Model Organism Business (2019-2024)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Detail
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Model Organism Introduction
11.16.4 Vitalstar Biotechnology Revenue in Model Organism Business (2019-2024)
11.16.5 Vitalstar Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂